The Global Vaccine Action Plan (GVAP) is a framework to improve health by extending the full benefits of immunization to all people. Approved by the World Health Assembly in May 2012, the GVAP was created to achieve the Decade of Vaccines’ vision of delivering universal access to immunization by 2020.
January 27, 2014
January 9, 2014
SEOUL, SOUTH KOREA - The Dengue Vaccine Initiative (DVI) announced today that it has received a 1 million Euro award from the German Federal Ministry of Education and Research (BMBF), the first time it has received such a grant from Germany. The funds will be used to support the development of new dengue vaccines in collaboration with the Instituto Butantan, a biomedical research center in São Paulo, Brazil, and Vabiotech, a vaccine manufacturer in Hanoi, Vietnam.